Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Behavioural Brain Research|May 9, 2002
Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependentKelly A Young, Melissa L Berry, Connie L Mahaffey, et al.Journal of Medicinal Chemistry|January 15, 2016
Robenidine Analogues as Gram-Positive Antibacterial AgentsRebecca J Abraham, Andrew J Stevens, Kelly A Young, et al.Molecular Cancer Therapeutics|July 14, 2011
Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cellsMegan Chircop, Swetha Perera, Anna Mariana, et al.Microbiology Spectrum|April 30, 2026
In vitro activity of robenidine analogue NCL195 against methicillin-resistant Staphylococcus pseudintermediusSayara Bista, Hang Thi Nguyen, Tatiana P Soares da Costa, et al.Cancer Investigation|March 26, 2019
Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for GlioblastomaRodney Luwor, Andrew P Morokoff, Stephanie Amiridis, et al.RSC Medicinal Chemistry|August 18, 2023
The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal modelsLuke R Odell, Nigel C Jones, Ngoc Chau, et al.ACS Chemical Biology|June 18, 2026
Sulfonadyn Compounds: A Class of Aryl Sulfonamides That Inhibit Dynamin GTPase and Clathrin-Mediated Endocytosis and Are Antiepileptic in Animal ModelsNigel C Jones, Mark J Robertson, Luke R Odell, et al.ACS Chemical Biology|May 7, 2013
Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitorsAndrew B McGeachie, Luke R Odell, Annie Quan, et al.Pageof 6